STEVEN GRUENSTEIN M.D. NPI 1407855307

NPI Details

Steven Gruenstein, M.D. is a hematology and oncology internal medicine in New York, NY with 41 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Steven Gruenstein, M.D. NPI is 1407855307. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

12 E 86TH ST OFC 4
NEW YORK, NY
ZIP 10028-517
Phone: (212) 861-6660
Fax: (212) 744-4696

The NPI 1407855307 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Uric acid level, blood (HCPCS:84550)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Protein measurement, serum (HCPCS:84165)
• Red blood count, manual test (HCPCS:85044)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Folic acid level, serum (HCPCS:82746)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Ige (immune system protein) level (HCPCS:82785)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Hemoglobin a1c level (HCPCS:83036)
• Injection of drug or substance into vein (HCPCS:96374)
• Vitamin d-3 level (HCPCS:82306)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Blood test, clotting time (HCPCS:85610)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Bilirubin level, total (HCPCS:82247)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Acute hepatitis panel (HCPCS:80074)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Blood smear for iron (HCPCS:85536)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Testosterone (hormone) level, total (HCPCS:84403)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Fibrinogen (factor 1) activity measurement (HCPCS:85384)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Bilirubin level, direct (HCPCS:82248)
• Urinalysis, manual test (HCPCS:81002)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Rheumatoid factor level (HCPCS:86431)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Influenza vaccine split virus, preservative free (HCPCS:90662)

The enumeration date for this NPI number is 7/21/2005 and was last updated on 1/17/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: